Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Weight-Loss drug protect your muscles? new study investigates

NCT ID NCT07373834

Recruiting now Disease control Sponsor: University Medical Centre Ljubljana Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether tirzepatide, a drug used for weight loss, affects muscle function and structure in women with obesity. Thirty premenopausal women will receive either tirzepatide or a placebo for 24 weeks. Researchers will measure changes in body composition, muscle strength, and take muscle biopsies to understand how the drug impacts muscle health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Tirzepatide (a drug that mimics two gut hormones to help with weight loss)
What this could lead to
If successful, this could show that tirzepatide helps preserve muscle strength and quality during weight loss, pointing toward better obesity treatments.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to everyone. It also does not test long-term safety or effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY (DISORDER)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana

    RECRUITING

    Ljubljana, 1000, Slovenia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.